Cargando…
Implications of m6A methylation and microbiota interaction in non-small cell lung cancer: From basics to therapeutics
N6-methyladenine (m6A) is one of the most common RNA epigenetic modifications in all higher eukaryotes. Increasing evidence demonstrated that m6A-related proteins, acted as oncogenes or tumor suppressors, are abnormally expressed in the cell lines and tissues of non-small cell lung cancer (NSCLC). I...
Autores principales: | Qiu, Fen-Sheng, He, Jia-Qi, Zhong, Yu-Sen, Guo, Mei-Ying, Yu, Chen-Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478539/ https://www.ncbi.nlm.nih.gov/pubmed/36118041 http://dx.doi.org/10.3389/fcimb.2022.972655 |
Ejemplares similares
-
Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer
por: Ying, Hua-Zhong, et al.
Publicado: (2022) -
Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer
por: He, Jia-Qi, et al.
Publicado: (2022) -
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
por: Fang, Jie, et al.
Publicado: (2022) -
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
por: Zhang, Yu-Lin, et al.
Publicado: (2022) -
Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota
por: Ding, Qi-You, et al.
Publicado: (2020)